An Overview of Continuing Medical Education/Continuing Professional Development Systems in the Middle East and North Africa: A Mixed Methods Assessment Authors: Lawrence Sherman, Samar Aboulsoud, Kathy Chappell Published: 2024 ABSTRACT ABSTRACTThe aims of this assessment were to describe the requirements for physicians to engage in CME/CPD; explore perceptions of in-country SMEs of their CME/CPD systems; describe perceptions of in-country physicians about interprofessional continuing education (IPCE) and independent CME/CPD; and provide recommendations that may be adopted to improve quality and effectiveness. An assessment of CME/CPD systems in the Middle East and North Africa was conducted using a mixed-methods approach that included 1:1 interviews with in-country SMEs and an electronic survey capturing qualitative and quantitative data from practicing in-country physicians. The results of this assessment were strongly influenced by Egypt and Israel in the Middle East, and Algeria and Morocco in North Africa. The CME/CPD systems demonstrate wide variation from absent/immature systems to robust/mature systems. Strategies to improve the quality of the CME/CPD systems range from implementing basic standards in North Africa to evaluating the impact of CME/CPD in practice in the Middle East. The maturity of CME/CPD systems seems to affect physician awareness, independence from the influence of pharmaceutical companies over education, and IPCE, with more mature systems having a positive relationship to awareness, independence and engagement in IPCE. Maturity of CME/CPD systems is less tied to physician perceptions of value of CME/CPD, hours of participation, perceptions of what is missing from current systems, and preferred formats of education. Introduction The world’s population relies on the healthcare professional (HCP) workforce to keep them healthy, to receive care when they are ill or injured, and to help them manage chronic disease. It is therefore critical that practicing HCPs have opportunities to engage in high-quality, evidence-based continuing medical education (CME)/continuing professional development (CPD) that meets their learning needs and helps them maintain the necessary knowledge and skills over their professional careers. This manuscript describes the current state of the CME/CPD systems in 12 countries in the Middle East and North Africa as described by in-country SMEs via focused interviews as well as input from in-country physician practitioners from 16 countries via an electronic survey. This assessment includes the countries of Bahrain, Egypt, Iraq, Israel, Jordan, the Kingdom of Saudi Arabia (KSA), Kuwait, Lebanon, Libya, Oman, Qatar, the United Arab Emirates (UAE) and Yemen in the Middle East. This assessment also includes the countries of Algeria and Morocco in North Africa. The report compares the state of the CME/CPD systems in these countries to best practices in CME/CPD systems globally. This manuscript is one of a series of assessments that also include China, Europe, and Latin America following a similar format [1]. This manuscript builds on previous regional assessments funded by independent educational grants from Pfizer in the country of Japan and within the Asian-Pacific countries of Hong Kong, Indonesia, Malaysia, Philippines, Singapore, Taiwan, and Thailand [2,3]. Overview The countries that are represented by in-country SMEs in this assessment (Appendix A) have physician per 1000 people ratios that vary widely, ranging from 0.7 physicians/1000 people in Egypt (2019) to 3.7 physicians/1000 people in Israel (2021) [4]. Medical Education Systems With the exception of the KSA, academic preparation for physicians in these countries follows two general paths and both begin after successful completion of secondary school. The first path requires an average of 6–7 years to complete and confers a medical degree. The first path incorporates medical school and practice-based training (internship or general practice). The second path requires 8 years to complete and confers both a baccalaureate degree and a medical degree. Physicians graduating from medical school in the second path often complete internship and/or residency programmes as a requirement to graduate. Four of the 12 countries in this assessment have both paths available concurrently. In the KSA, physicians are prepared through a baccalaureate degree programme only and must also complete internship and/or fellowship programmes to practice medicine. Graduates in all countries can specialise through residency and/or fellowship training. Tuition is heavily subsidised by the government of each country or is free. The practice of medicine in each country is governed by a national body, most often a Ministry of Health. CME/CPD Requirements for Physicians There is no requirement for physicians to participate in CME/CPD as a condition of licensure and to practice medicine in 5 of 12 countries in this assessment (Algeria, Israel, Lebanon, Morocco, and Oman). One country (Egypt) recently passed a law requiring physicians to participate in CME/CPD after 2020. In six countries, physicians must engage in CME/CPD as a condition of licensure and to practice medicine (Kingdom of Bahrain, UAE, Jordan, KSA, Kuwait, and Qatar). For countries requiring participation in CME/CPD as a condition of licensure and to practice medicine, credits are awarded in hours, points, or units. Hours are calculated as time spent engaged in the educational activity, while points or units are calculated using a matrix as defined by the individual regulatory body and are generally based on the type of educational activity and/or length of time engaged in the educational activity [5] More points and/or credits are awarded to educational activities that are perceived as more valuable/impactful or those that are longer. For example, more points may be awarded to a physician who participates in a medical symposium or teaches within a school of medicine as compared to reading a journal article. Additionally, more credits may be awarded for an educational activity lasting 8 hours as compared to one lasting 1 hour. In countries without mandatory participation, physicians are still encouraged to engage in CME/CPD, and participation may be recommended by or enforced by the employer. In most countries in this assessment, there is a regulatory body for CME/CPD even if participation is not required as a condition of licensure or to practice medicine. The regulatory body may be the same governing body for the practice of medicine (licensure) or may be driven by a medical professional association. CME/CPD Provider System The CME/CPD provider systems, defined as organisations that develop CME/CPD educational activities, in these countries are primarily regulated by a medical professional association or speciality organisation. Types of organisations that can provide CME/CPD include medical associations, hospitals and health departments, colleges and universities, and approved training organisations. Pharmaceutical companies have influence over the CME/CPD systems through direct provision, control, or funding in six of the countries in this assessment while the remaining countries have implemented regulations to separate influence and control. Physicians in these countries in the Middle East and North Africa have an opportunity to participate in CME/CPD in multiple types of formats that may include, but are not limited to, live and web-based educational programmes, conferences and scientific meetings, simulation, skills or practice-based education, and scholarly publications. Physicians can also receive credit for self-directed learning activities based on the rules or regulations as established by the professional association or governmental body. Review of the Literature on CME/CPD in the Middle East and North Africa A focused review of the literature on CME/CPD in the Middle East and North Africa was conducted using electronic databases (MEDLINE, PubMed, and CINAHL), with inclusion criteria of availability in English, full text, research studies, and published in a peer review journal within the past 15 years. The literature review was expanded to include one seminal article published in 2006 regarding the historical background in the region and expanded to include theses and conference presentations identified by the Regional SME. A summary of the articles reviewed is provided below. Historical Background A Committee for CME/CPD in the Gulf Cooperation Council (GCC) was established in 200 to coordinate and promote the CME/CPD initiatives among the GCC countries. The Committee facilitated awareness about CME/CPD and introduced the concept of mutual recognition of CPD credits within the GCC countries. Furthermore, there was discussion regarding the formalisation of GCC Alliance in CPD [6]. System Comparisons A comparative analysis of CME/CPD frameworks and accreditation systems was undertaken by Hussain et al. in 2016. The principle findings can be summarised into four themes: differences in governance structures, discrepancies in the total credit requirements as well as between different health professions, the presence of an accreditation system, and the mandatory participation in CME/CPD activities for maintenance of licensure. CME/CPD: Challenges and Barriers Our literature review identified a number of research papers that addressed challenges and barriers to the development and implementation of CME/CPD. A cross-sectional study that was conducted amongst primary care physicians in Qatar reported lack of time and cost as the main challenges to participation in CME/CPD activities [7]. In an earlier study of the primary care physicians in Alahsa, KSA, researchers found that poor teaching methodologies, irrelevance of topics and physicians’ inclination to self-learning, dissatisfaction with available CME resources and lack of computers in the workplace, high patient load, and multiple work responsibilities were barriers to participation in CME [8]. A Jordanian study concluded that CPD practice is jeopardised by the lack of mandatory laws in addition to challenges related to staff shortages, work overload, lack of time, and cost [9]. In her research of the status of CME in the KSA governmental hospitals, Alghamdi [10] described the major CME challenges and categorised them into four main themes: management, including the lack of appreciation of decision makers about the importance of CME, and their influence over the planning of learning programmes; lack of resources and poor access to medical libraries; CME budget constraints which amplified the influence of pharmaceutical industry on CME practice; cultural diversity of physicians, including different physicians’ educational backgrounds, and resistance to change their performance after the completion of a CME activity or programme. Perceptions, Good Practice and Lessons Learnt A study of the perceptions of CME activities among primary care physicians in Bahrain reported a positive overall experience and recommended that financial support and protected time should be secured to further enhance the CME practice. The study highlighted the need for a formal CME committee in health institutions to support and provide continuous oversight for CME activities within the institution [11]. Capacity Building in the Health Professions One publication outlined a cooperative strategy among Gulf Coast Countries (GCC) in the Middle East to address critical shortages of nationally trained HCPs and an over-reliance on an expatriate health care workforce [12]. Following reports issued by the World Health Organization (WHO) Regional Office for the Eastern Mediterranean in 2014, 2016 and 2017, and a call for capacity building of the health care workforce in the GCC, the authors describe the process of analysing the current gaps in capacity and identifying areas of success that could be replicated. The authors cite the development of CME/CPD activities as crucial to increasing health care capacity. Specific recommendations include conducting country-specific needs assessments, post-remediation programmes, assessment of the impact of CME/CPD on healthcare professional and patient levels, assessing the number of trained HCPs working in the country, and identifying areas requiring additional improvement [12]. Recommendations also included an emphasis on incorporating culturally appropriate CME/CPD activities and implementing a multidisciplinary approach. The authors share numerous strategic partnerships across GCC countries as well as strategic partnerships between GCC and the WHO, and between the GCC and non-GCC organisations. Design and Implementation of a CPD System for Healthcare Professionals in Egypt In 2018, the Egyptian government approved legislation requiring the establishment of a regulatory authority for CPD and expectations of participation in CPD as a condition of relicensure for physicians [13]. Subsequently, the regulatory authority created a provider accreditation model that established criteria for educational quality, learning outcomes, independence from influence of commercial interest organisations, and tracking of learners. The authors share outcomes that include the number of accredited CPD providers, number of CPD activities, the types of organisations that achieved accreditation, and the steps taken to ensure independence between commercial interest organisations and CME/CPD. The authors describe how the strong regulatory framework and emphasis on quality education are leading to the aim of achieving international recognition. Limitations of the Literature Review The majority of the literature analysed explored the perceptions of primary care physicians in different countries in the Middle East. It is recommended to consider a more inclusive research approach that explores perspectives of physicians in tertiary care and other HCPs. Published CME/CPD research is particularly lacking in some Northern African countries e.g. Algeria, Tunisia and Morocco, and much of it was published more than ten years ago. Mixed-Methods Assessment Strategy To evaluate each country in greater depth and to assess the overall perception of the CME/CPD systems in the Middle East and North Africa from a broad group of physicians, a mixed-methods assessment strategy was employed in a three-pronged approach that included 1:1 interviews with In-Country SMEs facilitated by a Regional SME, and an electronic survey to capture both quantitative and qualitative data from in-country physicians (Appendix B). The survey that was used to capture data from in-country physicians was used in two previous assessments conducted in Japan and the Asia-Pacific region; therefore, the results of this assessment provide an opportunity to compare results globally [2,3]. The survey captured demographic data as well as self-report data from in-country physicians that reflected characteristics of the CME/CPD system in their countries, perceptions of industry-supported CME/CPD, and perceptions of how well the current CME/CPD systems were meeting physicians’ educational needs. In this assessment, CME and CPD were defined as: CME: educational activities which serve to maintain, develop, or increase the knowledge, skills, and professional performance and relationships that a physician uses to provide services for patients, the public, or the profession [14].CPD: educational activities to enhance medical competence in medical knowledge and skills, but also in management, team building, professionalism, interpersonal communication, technology, teaching, and accountability [15]. CME: educational activities which serve to maintain, develop, or increase the knowledge, skills, and professional performance and relationships that a physician uses to provide services for patients, the public, or the profession [14]. CME: educational activities which serve to maintain, develop, or increase the knowledge, skills, and professional performance and relationships that a physician uses to provide services for patients, the public, or the profession [14]. CPD: educational activities to enhance medical competence in medical knowledge and skills, but also in management, team building, professionalism, interpersonal communication, technology, teaching, and accountability [15]. CPD: educational activities to enhance medical competence in medical knowledge and skills, but also in management, team building, professionalism, interpersonal communication, technology, teaching, and accountability [15]. In this assessment, IPCE was defined as: IPCE: when members from two or more professions learn with, from, and about each other to enable effective collaboration and improve health outcomes. IPCE relates to practicing HCP team-based education. In comparison, interprofessional education (IPE) relates to undergraduate health care students [16]. IPCE: when members from two or more professions learn with, from, and about each other to enable effective collaboration and improve health outcomes. IPCE relates to practicing HCP team-based education. In comparison, interprofessional education (IPE) relates to undergraduate health care students [16]. IPCE: when members from two or more professions learn with, from, and about each other to enable effective collaboration and improve health outcomes. IPCE relates to practicing HCP team-based education. In comparison, interprofessional education (IPE) relates to undergraduate health care students [16]. In this assessment, independent CME/CPD was defined as: CME/CPD for which financial, or in-kind, contributions given by a commercial interest, which is used to pay all or part of the costs of an activity. The definition of roles and requirements when commercial support is received are outlined in the Accreditation Council of Continuing Medical Education (ACCME) Standards for Commercial Support and although this is a United States (US)-based organisation, it is accepted as the standard for defining roles and responsibilities. The commercial supporter cannot be involved in the planning, delivery, or evaluation of the educational activities and all decisions are made by the educational provider [17]. CME/CPD for which financial, or in-kind, contributions given by a commercial interest, which is used to pay all or part of the costs of an activity. The definition of roles and requirements when commercial support is received are outlined in the Accreditation Council of Continuing Medical Education (ACCME) Standards for Commercial Support and although this is a United States (US)-based organisation, it is accepted as the standard for defining roles and responsibilities. The commercial supporter cannot be involved in the planning, delivery, or evaluation of the educational activities and all decisions are made by the educational provider [17]. CME/CPD for which financial, or in-kind, contributions given by a commercial interest, which is used to pay all or part of the costs of an activity. The definition of roles and requirements when commercial support is received are outlined in the Accreditation Council of Continuing Medical Education (ACCME) Standards for Commercial Support and although this is a United States (US)-based organisation, it is accepted as the standard for defining roles and responsibilities. The commercial supporter cannot be involved in the planning, delivery, or evaluation of the educational activities and all decisions are made by the educational provider [17]. This assessment was led by an independent health professions educator (HPE) with 27 years of experience in global CPD and IPCE, who also holds an international development role within the Association for Medical Education in Europe (AMEE). The HPE recruited a regional SME from Egypt to assist with the study in the Middle East. The Egyptian SME facilitated the recruitment of in-country SMEs from the Middle East, reviewed the survey to ensure contextual relevance, and supported survey dissemination in the region. The HPE also recruited a regional SME from Algeria to assist with the study in North Africa. The Algerian SME facilitated the recruitment of in-country SMEs from North Africa and supported survey dissemination in the region. The Algerian SME also translated the survey into French and provided back-translation of free text responses into English. Each in-country SME participated in a 1:1 focused interview with the HPE and regional SME to provide an overview of their CME/CPD system. In-country SMEs used PowerPoint presentations and open discussion to deliver the content. Interviews (Appendix C) lasted between 30 and 60 minutes and were guided by the HPE using a standard set of questions. All interviews were conducted in English and translation was not required. Interviews were also attended by a doctorally-prepared researcher who transcribed notes for the subsequent report/manuscript. Country-level data were summarised in table format and sent back to the in-country SME for validation. In-country SMEs confirmed the data and/or made changes to ensure the data were accurate. The electronic survey that was used to capture quantitative and qualitative data from in-country physicians throughout the Middle East and North Africa was provided in English to the in-country physicians throughout the Middle East and in French to the in-country physicians in North Africa. Per the regional SMEs, physicians throughout the Middle East were comfortable responding to the survey in English while physicians in North Africa would be more apt to respond if the survey was translated. Throughout the countries, the survey was disseminated electronically using SurveyMonkey® by the in-country SMEs who also engaged partner organisations if needed. Purposive, heterogeneous sampling was used to access respondents as the aim of this assessment was to capture the perceptions of physicians who represented diversity across specialities, practice settings, age, gender, and experience. Respondents self-selected to participate and no remuneration for participation was given. There were 12 countries represented by regional SMEs and a total of 16 countries that had respondents to the survey. Institutional Review Board (IRB) Approval This assessment was conducted in accordance with the principles embodied in the Declaration of Helsinki and in accordance with local statutory requirements. Dissemination The survey in the Middle East and North Africa was opened on 27 November 2020 for a total of 20 weeks and 4 days, and was closed on 20 April 2021. When necessary, reminders were sent to maximise participation. The survey remained open for the extended period to allow partner organisations to disseminate and to maximise the number of respondents. Following the survey close, data were downloaded from SurveyMonkey® and free text items were translated from French into English by the Algerian SME. Data Analysis Middle East Cohort For the Middle East cohort, the original data file included 550 rows of respondent data including quantitative data and free text responses in English. All personal identifiers including IP address were immediately removed from the data file and analysis was performed only using the deidentified file. A case number was created for each respondent row to track and ensure accuracy during the analysis process. To ensure duplicates were not counted more than once, the researchers deduplicated the survey responses before conducting the analysis. A review of countries reported by respondents was conducted to ensure that all respondents practiced in the Middle East. A total of 12 cases were removed from the data set due to a respondent who practiced outside the Middle East. A total of 60 cases were removed from the data set due to respondents who failed to enter any country name into the free text box. There were 104 cases that were removed from the original data file because the respondent failed to answer the item “Do you have formal training/coursework in medical education” (e.g. the item was left blank; N = 37) or the respondent failed to continue the survey after that item (e.g. no further data were entered by the respondent; N = 67). Analysis was conducted on the final data set of 374 respondents which represented 68% of all starters (Figure 1). A modest drop off continued throughout the survey which was noted as “missing data” on each table.Figure 1.Continued. Continued. North Africa Cohort For the North Africa cohort, the original data file included 74 rows of respondent data including quantitative data, free text responses in French, and translated responses in English. All personal identifiers including IP address were immediately removed from the data file and analysis was performed on the deidentified file. A case number was created for each respondent row to track and ensure accuracy during the analysis process. A review of countries reported by respondents was conducted to ensure that all respondents practiced in North Africa. No cases were removed from the data set due to a respondent who practiced outside North Africa. There were no duplicate entries. There were 29 cases that were removed from the original data file because the respondent failed to answer the item “Do you have formal training/coursework in medical education” (e.g. the item was left blank; N = 16) or the respondent failed to continue the survey after that item (e.g. no further data were entered by the respondent; N = 13). Analysis was conducted on the final data set of 45 respondents which represented 61% of all starters (Figure 1). A modest drop off continued throughout the survey which was noted as “missing data” on each table.Figure 1.Data cleaning for analysis for Middle East and North Africa Cohorts.*Note: Respondent drop off over survey noted in tables as missing data. Data cleaning for analysis for Middle East and North Africa Cohorts. Both Cohorts Quantitative analyses were conducted using IBM SPSS Statistical software Version 28 and included descriptive statistics (mean, standard deviation, %). Analysis was conducted on the qualitative data collected via the survey (e.g. open response questions) who aggregated and summarised comments by overall theme as they related to the survey item. The six-step process used for thematic analysis was: familiarisation, coding, generating themes, reviewing themes, defining and naming themes, and writing up themes was followed for this analysis [18]. Qualitative analysis was conducted on the interview responses and open-ended questions on the survey. Results Physicians from across 16 countries throughout the Middle East and North Africa responded to the electronic survey. The following is an aggregate summary of the quantitative and qualitative data captured through the survey. Qualitative data provided by in-country SMEs via focused interviews that reflect their perspectives are also presented in summary. Quantitative Survey Data Demographics (Table 1) A total of 374 physicians from the Middle East and 45 physicians from North Africa were included in this analysis. In the Middle East, the largest volume of respondents were from Israel (N = 168) and Egypt (N = 126). In North Africa, most respondents were from Morocco (N = 35). In both cohorts, more respondents practiced in general practice than in any other single speciality or sub-speciality. In the Middle East, a substantial number of respondents practiced in internal medicine or an internal medicine subspeciality, in paediatrics, or in obstetrics/gynaecology. There were no respondents who practiced in surgery, a surgery subspeciality, or in obstetrics/gynaecology from the North Africa cohort. In the Middle East, more respondents practiced in a hospital than in any other practice setting, while 23% reported “other” as their practice setting. Free text responses in “other” included primarily private hospitals and clinic settings. In North Africa, 57.7% of respondents practiced in a hospital setting, and a substantial number of respondents practiced in a location classified as “other”. Free text responses to “other” reflected private practice or clinic settings and speciality clinic settings. Most respondents in both cohorts practiced in large cities. In the Middle East cohort, most respondents graduated from medical school more than 25 years ago, and the remaining respondents were evenly distributed through the remaining categories. In the North Africa cohort, respondents were more evenly distributed among the categories of years since graduation. Most respondents practiced clinically and reported seeing patients. In the Middle East cohort, the average number of patients seen per day for those in clinical practice averaged 23.21 (SD 16.92); and in the North Africa cohort, the average number of patients seen per day was slightly higher at 28.26 (SD 18.20). When asked if they had responsibility for teaching medical students, resident doctors, clinical specialists (consultants) or “other”, most respondents in both the Middle East and North Africa cohorts reported being responsible for “other”. As the survey item was asked as a single response choice, those who selected “other” reported not being responsible for teaching at all, being responsible for teaching multiple groups within medicine, or being responsible for teaching within medicine and with other health professionals. Most respondents in both the Middle East and North Africa cohorts reported having no formal training or coursework in medical education. Formal training or coursework was not formally defined therefore respondents were responsible for evaluating their own situation and responding accordingly.Table 1.Demographic characteristics of respondents. Middle EastNumber of respondents included in analysis (N)374Specialty area of practice (%) General Practice25.4% Internal Medicine13.6% Internal Medicine Subspecialty12.6% Pediatrics20.1% Surgery7.5% Surgery Specialty4.8% Obstetrics/Gynecology16.0% Psychiatry0% Other0%Place of employment (%) University Hospitals32.1% Affiliated Hospital8.6% Government Hospital22.2% Community Hospital6.7% Medical College (as Teaching Faculty)5.6% Other (non-specified)23.0% I do not do clinical work.1.9%Years since graduation (%) <69.4% 6–109.6% 11–1514.7% 16–2011.2% 21–2511.2% >2540.6% I do not treat patients.3.2%Average number of patients seen per day (mean/standard deviation)N = 36119.35 (SD 17)Responsibility for educating others Medical Students26.7% Postgraduate Residents25.1% Clinical Specialists (Consultants)11.2% Other36.9%Formal training in medical education Yes22.5% No57.8% Other (with explanation)19.8% North AfricaNumber of respondents included in analysis (N) Specialty area of practice (%)45General Practice77.8%Internal Medicine15.6%Internal Medicine Subspecialty0%Pediatrics6.7%Surgery0%Surgery Specialty0%Obstetrics/Gynecology0%Psychiatry0%Other0%Place of employment (%) University Hospitals17.8%Affiliated Hospital2.2%Government Hospital24.4%Community Hospital13.3%Medical College (as Teaching Faculty)4.4%Other (non-specified)37.8%I do not do clinical work.0Years since graduation (%) <617.8%6–108.9%11–1524.4%16–2015.6%21–256.7%>2522.2%I do not treat patients.4.4%Average number of patients seen per day (mean/standard deviation)N = 4523.87 (SD 19)Responsibility for educating others Medical Students22.2%Postgraduate Residents6.7%Clinical Specialists (Consultants)13.3%Other57.8%Formal training in medical education Yes15.6%No73.3%Other (with explanation)11.1% Table 1.Demographic characteristics of respondents. Middle EastNumber of respondents included in analysis (N)374Specialty area of practice (%) General Practice25.4% Internal Medicine13.6% Internal Medicine Subspecialty12.6% Pediatrics20.1% Surgery7.5% Surgery Specialty4.8% Obstetrics/Gynecology16.0% Psychiatry0% Other0%Place of employment (%) University Hospitals32.1% Affiliated Hospital8.6% Government Hospital22.2% Community Hospital6.7% Medical College (as Teaching Faculty)5.6% Other (non-specified)23.0% I do not do clinical work.1.9%Years since graduation (%) <69.4% 6–109.6% 11–1514.7% 16–2011.2% 21–2511.2% >2540.6% I do not treat patients.3.2%Average number of patients seen per day (mean/standard deviation)N = 36119.35 (SD 17)Responsibility for educating others Medical Students26.7% Postgraduate Residents25.1% Clinical Specialists (Consultants)11.2% Other36.9%Formal training in medical education Yes22.5% No57.8% Other (with explanation)19.8% Demographic characteristics of respondents. North AfricaNumber of respondents included in analysis (N) Specialty area of practice (%)45General Practice77.8%Internal Medicine15.6%Internal Medicine Subspecialty0%Pediatrics6.7%Surgery0%Surgery Specialty0%Obstetrics/Gynecology0%Psychiatry0%Other0%Place of employment (%) University Hospitals17.8%Affiliated Hospital2.2%Government Hospital24.4%Community Hospital13.3%Medical College (as Teaching Faculty)4.4%Other (non-specified)37.8%I do not do clinical work.0Years since graduation (%) <617.8%6–108.9%11–1524.4%16–2015.6%21–256.7%>2522.2%I do not treat patients.4.4%Average number of patients seen per day (mean/standard deviation)N = 4523.87 (SD 19)Responsibility for educating others Medical Students22.2%Postgraduate Residents6.7%Clinical Specialists (Consultants)13.3%Other57.8%Formal training in medical education Yes15.6%No73.3%Other (with explanation)11.1% Perceptions of the Current In-Country CME/CPD System (Table 2) The majority of respondents in the Middle East cohort were aware of the CME/CPD systems in their countries, while only 31.1% of the respondents from the North Africa cohort reported being aware. Most respondents from both cohorts reported participating in less than 20 hours of CME/CPD in the past year. Most respondents in both cohorts strongly agreed or agreed that the CME/CPD available to them met their needs, strongly agreed or agreed that participating in CME/CPD ensures they have current knowledge to care for their patients, increases competence and skills, and should be compulsory. Most respondents in both cohorts believe that IPCE is needed in their countries, while just under half of respondents in each cohort had participated in IPCE.Table 2.Perspectives of In-country physicians: awareness and participation. Middle EastNumber of respondents included in analysis (N)374Aware of CME/CPD system in country (%) Yes53.7%No14.2%Not sure16.6%There is no formal system15.5%Hours of CME/CPD in past year 027.5%1–10No data11–2028.6%21–3012.0%31–4010.7%41–5010.7%>5010.4%CME/CPD available meets my needs Strongly agree23.0%Agree48.9%Disagree19.3%Strongly disagree8.8%Participation in CME/CPD should be compulsory Strongly agree29.9%Agree51.1%Disagree15.2%Strongly disagree3.7%IPCE is needed Yes79.4%No3.7%Not sure14.7%Missing2.1% North AfricaNumber of respondents included in analysis (N)45Aware of CME/CPD system in country (%) Yes31.1%No17.8%Not sure22.2%Missing28.9%Hours of CME/CPD in past year 031.1%1–10No data11–2020.0%21–3013.3%31–4017.8%41–506.7%>5011.1%CME/CPD available meets my needs Strongly agree28.9%Agree35.6%Disagree15.6%Strongly disagree20.0%Participation in CME/CPD should be compulsory Strongly agree86.7%Agree8.9%Disagree4.4%Strongly disagree0%IPCE is needed Yes91.1%No0%Not sure8.9% Table 2.Perspectives of In-country physicians: awareness and participation. Middle EastNumber of respondents included in analysis (N)374Aware of CME/CPD system in country (%) Yes53.7%No14.2%Not sure16.6%There is no formal system15.5%Hours of CME/CPD in past year 027.5%1–10No data11–2028.6%21–3012.0%31–4010.7%41–5010.7%>5010.4%CME/CPD available meets my needs Strongly agree23.0%Agree48.9%Disagree19.3%Strongly disagree8.8%Participation in CME/CPD should be compulsory Strongly agree29.9%Agree51.1%Disagree15.2%Strongly disagree3.7%IPCE is needed Yes79.4%No3.7%Not sure14.7%Missing2.1% North AfricaNumber of respondents included in analysis (N)45Aware of CME/CPD system in country (%) Yes31.1%No17.8%Not sure22.2%Missing28.9%Hours of CME/CPD in past year 031.1%1–10No data11–2020.0%21–3013.3%31–4017.8%41–506.7%>5011.1%CME/CPD available meets my needs Strongly agree28.9%Agree35.6%Disagree15.6%Strongly disagree20.0%Participation in CME/CPD should be compulsory Strongly agree86.7%Agree8.9%Disagree4.4%Strongly disagree0%IPCE is needed Yes91.1%No0%Not sure8.9% Perspectives of In-country physicians: awareness and participation. Preference in Educational Format When asked to rank educational format based on their preference and using a scale from 1 (low) to 5 (high), respondents selected 4 or 5 most often for the following formats: Middle East cohort Attending live regional educational activities (N = 162)Hands-on learning (N = 162)Attending national and international conferences/symposia (N = 155)Serving as a supervisory physician (N = 128)Online patient case-based learning (N = 128)North Africa cohort Hands-on learning (N = 26)Answering questions at the end of e-learning activities (N = 21)Attending live regional educational activities (N = 20)Attending national and international conferences/symposia (N = 19)Online patient case-based learning (N = 16) Middle East cohort Attending live regional educational activities (N = 162)Hands-on learning (N = 162)Attending national and international conferences/symposia (N = 155)Serving as a supervisory physician (N = 128)Online patient case-based learning (N = 128) Middle East cohort Attending live regional educational activities (N = 162)Hands-on learning (N = 162)Attending national and international conferences/symposia (N = 155)Serving as a supervisory physician (N = 128)Online patient case-based learning (N = 128) Attending live regional educational activities (N = 162) Attending live regional educational activities (N = 162) Hands-on learning (N = 162) Hands-on learning (N = 162) Attending national and international conferences/symposia (N = 155) Attending national and international conferences/symposia (N = 155) Serving as a supervisory physician (N = 128) Serving as a supervisory physician (N = 128) Online patient case-based learning (N = 128) Online patient case-based learning (N = 128) North Africa cohort Hands-on learning (N = 26)Answering questions at the end of e-learning activities (N = 21)Attending live regional educational activities (N = 20)Attending national and international conferences/symposia (N = 19)Online patient case-based learning (N = 16) North Africa cohort Hands-on learning (N = 26)Answering questions at the end of e-learning activities (N = 21)Attending live regional educational activities (N = 20)Attending national and international conferences/symposia (N = 19)Online patient case-based learning (N = 16) Hands-on learning (N = 26) Hands-on learning (N = 26) Answering questions at the end of e-learning activities (N = 21) Answering questions at the end of e-learning activities (N = 21) Attending live regional educational activities (N = 20) Attending live regional educational activities (N = 20) Attending national and international conferences/symposia (N = 19) Attending national and international conferences/symposia (N = 19) Online patient case-based learning (N = 16) Online patient case-based learning (N = 16) Perceptions of Industry-Supported CME/CPD (Table 3) In the Middle East cohort, 53.5% of respondents strongly agreed or agreed that the CME/CPD in their country was free from control by pharmaceutical or other commercial interests; in the North African cohort, 53.4% strongly agreed or agreed with the same item. In the Middle East cohort, 52.1% and in the North Africa cohort, 73.3% of respondents had participated in independent, commercially supported CME. In the Middle East cohort, 48.6%, and in the North Africa cohort, 68.9% strongly agreed or agreed that CME/CPD funded by pharmaceutical or other commercial interest organisations can be free from bias.Table 3.Perceptions of In-country physicians: independence and commercial Influence/Bias. Middle EastNumber of respondents included in analysis (N)374CME/CPD in my country is free from control by pharmaceutical or other commercial interests Strongly agree12.3% Agree41.2% Disagree24.3% Strongly disagree16.8% Missing16.8%I have participated in CME/CPD that has been developed by independent CME/CPD providers with financial support from pharmaceutical or other commercial interest organizations Yes52.1% No31.0% Missing16.8%CME/CPD funded by pharmaceutical or other commercial interest organizations can be free from bias: Strongly agree8.8% Agree39.8% Disagree29.4% Strongly disagree5.1% Missing16.8% North AfricaNumber of respondents included in analysis (N)45CME/CPD in my country is free from control by pharmaceutical or other commercial interests Strongly agree37.8% Agree15.6% Disagree24.4% Strongly disagree17.8% Missing4.4%I have participated in CME/CPD that has been developed by independent CME/CPD providers with financial support from pharmaceutical or other commercial interest organizations Yes73.3% No22.2% Missing4.4%CME/CPD funded by pharmaceutical or other commercial interest organizations can be free from bias: Strongly agree35.6% Agree33.3% Disagree17.8% Strongly disagree8.9% Missing4.4% Table 3.Perceptions of In-country physicians: independence and commercial Influence/Bias. Middle EastNumber of respondents included in analysis (N)374CME/CPD in my country is free from control by pharmaceutical or other commercial interests Strongly agree12.3% Agree41.2% Disagree24.3% Strongly disagree16.8% Missing16.8%I have participated in CME/CPD that has been developed by independent CME/CPD providers with financial support from pharmaceutical or other commercial interest organizations Yes52.1% No31.0% Missing16.8%CME/CPD funded by pharmaceutical or other commercial interest organizations can be free from bias: Strongly agree8.8% Agree39.8% Disagree29.4% Strongly disagree5.1% Missing16.8% North AfricaNumber of respondents included in analysis (N)45CME/CPD in my country is free from control by pharmaceutical or other commercial interests Strongly agree37.8% Agree15.6% Disagree24.4% Strongly disagree17.8% Missing4.4%I have participated in CME/CPD that has been developed by independent CME/CPD providers with financial support from pharmaceutical or other commercial interest organizations Yes73.3% No22.2% Missing4.4%CME/CPD funded by pharmaceutical or other commercial interest organizations can be free from bias: Strongly agree35.6% Agree33.3% Disagree17.8% Strongly disagree8.9% Missing4.4% Perceptions of In-country physicians: independence and commercial Influence/Bias. Participation in Pharmaceutical or Commercially Supported CME/CPD (Table 4) Most respondents strongly agreed or agreed that content developed independently by a CME/CPD education company could be used towards their required educational hours or credit requirements, and almost half would choose to participate in independent CME/CPD if the content was based on their clinical speciality and/or the education was relevant to their practice.Table 4.Participation in pharma or commercially supported CME/CPD. Middle EastNumber of respondents included in analysis (N)374Independent CME/CPD should be used towards my requirements Strongly agree12.8% Agree55.1% Disagree11.0% Strongly disagree4.3% Missing16.8%If CME/CPD funded by Pharma or a Commercial Interest was available to you, how would you choose to participate: Based on my clinical specialty58.3% Based on the presenting faculty22.2% Only when at least one presenting faculty member is from my country3.7% The relevance of the education to my practice47.1% Curiosity for the topic (but not necessarily related to my practice)27.0% The city where the meeting is located19.0% I could not participate in independent CME/CPD funded by a pharmaceutical or other commercial interest organization6.7% Other0 North AfricaNumber of respondents included in analysis (N)45Independent CME/CPD should be used towards my requirements Strongly agree40.0% Agree46.7% Disagree0% Strongly disagree8.9% Missing4.4%If CME/CPD funded by pharma or a commercial interest was available to you, how would you choose to participate: Based on my clinical specialty62.2% Based on the presenting faculty13.3% Only when at least one presenting faculty member is from my country0% The relevance of the education to my practice60% Curiosity for the topic (but not necessarily related to my practice)31.1% The city where the meeting is located28.9% I could not participate in independent CME/CPD funded by a pharmaceutical or other commercial interest organization0% Other0% Table 4.Participation in pharma or commercially supported CME/CPD. Middle EastNumber of respondents included in analysis (N)374Independent CME/CPD should be used towards my requirements Strongly agree12.8% Agree55.1% Disagree11.0% Strongly disagree4.3% Missing16.8%If CME/CPD funded by Pharma or a Commercial Interest was available to you, how would you choose to participate: Based on my clinical specialty58.3% Based on the presenting faculty22.2% Only when at least one presenting faculty member is from my country3.7% The relevance of the education to my practice47.1% Curiosity for the topic (but not necessarily related to my practice)27.0% The city where the meeting is located19.0% I could not participate in independent CME/CPD funded by a pharmaceutical or other commercial interest organization6.7% Other0 North AfricaNumber of respondents included in analysis (N)45Independent CME/CPD should be used towards my requirements Strongly agree40.0% Agree46.7% Disagree0% Strongly disagree8.9% Missing4.4%If CME/CPD funded by pharma or a commercial interest was available to you, how would you choose to participate: Based on my clinical specialty62.2% Based on the presenting faculty13.3% Only when at least one presenting faculty member is from my country0% The relevance of the education to my practice60% Curiosity for the topic (but not necessarily related to my practice)31.1% The city where the meeting is located28.9% I could not participate in independent CME/CPD funded by a pharmaceutical or other commercial interest organization0% Other0% Participation in pharma or commercially supported CME/CPD. Perceptions of Independence in CME/CPD (Table 5) Perceptions of CME/CPD developed by an independent provider with financial support from a pharmaceutical or other commercial interest organisation varied. Respondents from both cohorts believed that a pharmaceutical or commercial interest organisation can have influence into planning decisions in independent CME/CPD including reviewing and approving all content, suggesting speakers, and working with the educational provider to develop content. Less than 1/4 of respondents in either cohort reported that the pharmaceutical or commercial interest organisation can have no influence on content or speaker selection in independent CME/CPD. More respondents in the North Africa cohort reported that content is independently developed by the educational provider to address the needs of learners in independent CME/CPD as compared to respondents in the Middle East cohort. Just under 20% of respondents in the Middle East cohort and 8.9% of respondents in the North Africa cohort did not know what independent CME/CPD means.Table 5.Perspectives of In-country physicians: what independence in CME/CPD means. Middle EastNumber of respondents included in analysis (N)374CME/CPD that is developed by an independent CME provider with financial support from pharmaceutical or other commercial interest organizations means: Pharma or Commercial Interest must review and approve all content16.3% Pharma or Commercial Interest can suggest speakers26.7% Pharma or Commercial Interest works with the educational provider to develop content23.8% Pharma or Commercial Interest has no influence on content and speaker selection22.5% Content is developed independently by the education company to address the needs of learners22.2% I don’t know19.5% North AfricaNumber of respondents included in analysis (N)45CME/CPD that is developed by an independent CME provider with financial support from pharmaceutical or other commercial interest organizations means: Pharma or Commercial Interest must review and approve all content11.1% Pharma or Commercial Interest can suggest speakers42.2% Pharma or Commercial Interest works with the educational provider to develop content26.7% Pharma or Commercial Interest has no influence on content and speaker selection24.4% Content is developed independently by the education company to address the needs of learners31.1% I don’t know8.9% Table 5.Perspectives of In-country physicians: what independence in CME/CPD means. Middle EastNumber of respondents included in analysis (N)374CME/CPD that is developed by an independent CME provider with financial support from pharmaceutical or other commercial interest organizations means: Pharma or Commercial Interest must review and approve all content16.3% Pharma or Commercial Interest can suggest speakers26.7% Pharma or Commercial Interest works with the educational provider to develop content23.8% Pharma or Commercial Interest has no influence on content and speaker selection22.5% Content is developed independently by the education company to address the needs of learners22.2% I don’t know19.5% North AfricaNumber of respondents included in analysis (N)45CME/CPD that is developed by an independent CME provider with financial support from pharmaceutical or other commercial interest organizations means: Pharma or Commercial Interest must review and approve all content11.1% Pharma or Commercial Interest can suggest speakers42.2% Pharma or Commercial Interest works with the educational provider to develop content26.7% Pharma or Commercial Interest has no influence on content and speaker selection24.4% Content is developed independently by the education company to address the needs of learners31.1% I don’t know8.9% Perspectives of In-country physicians: what independence in CME/CPD means. Missing from Current CME/CPD System and Barriers to Participation (Table 6) When asked what was missing from their current CME/CPD systems, respondents from each cohort ranked the following the highest: Middle East cohort Ability to choose education that suits my specific needs (28.3%)Patient-focused programmes (23.3%)Variety of educational formats (20.9%)North Africa cohort Ability to choose education that suits my specific needs (42.2%)Ability to network with colleagues (40%)More frequent and diverse programmes (35.6%) Middle East cohort Ability to choose education that suits my specific needs (28.3%)Patient-focused programmes (23.3%)Variety of educational formats (20.9%) Middle East cohort Ability to choose education that suits my specific needs (28.3%)Patient-focused programmes (23.3%)Variety of educational formats (20.9%) Ability to choose education that suits my specific needs (28.3%) Ability to choose education that suits my specific needs (28.3%) Patient-focused programmes (23.3%) Patient-focused programmes (23.3%) Variety of educational formats (20.9%) Variety of educational formats (20.9%) North Africa cohort Ability to choose education that suits my specific needs (42.2%)Ability to network with colleagues (40%)More frequent and diverse programmes (35.6%) North Africa cohort Ability to choose education that suits my specific needs (42.2%)Ability to network with colleagues (40%)More frequent and diverse programmes (35.6%) Ability to choose education that suits my specific needs (42.2%) Ability to choose education that suits my specific needs (42.2%) Ability to network with colleagues (40%) Ability to network with colleagues (40%) More frequent and diverse programmes (35.6%) More frequent and diverse programmes (35.6%) When asked what barriers existed that prevented them from participating in CME/CPD, the majority of respondents in each cohort reported the following: Middle East cohort No barriers (19.3%)Not covered in my budget (16.6%)Not offered at convenient times (16.6%) No barriers (19.3%) No barriers (19.3%) Not covered in my budget (16.6%) Not covered in my budget (16.6%) Not offered at convenient times (16.6%) Not offered at convenient times (16.6%) ● North Africa cohort Not covered in my budget (26.7%)Not offered at convenient times (13.3%)Not enough skill building exercise (11.1%)Table 6.Perceptions of In-country physicians: missing from CME/CPD System and barriers to participation. Middle EastNumber of respondents included in analysis (N)374What is missing from the CME/CPD currently available to you? Ability to choose education that suits my specific needs28.3% Ability to keep up to date with the most current research20.3% Ability to network with colleagues20.6% Content that is current/up to date13.9% Variety of educational formats (ie. Live, online, web-based, experiential, preceptorships)20.9% Innovative learning environments and new creative formats19.8% More frequent and more diverse programs19.5% Patient-focused programs23.3% Not applicable enough9.1% Nothing is missing11.0%What are your barriers to participating in CME/CPD (if any)? Not covered in my budget16.6% Topics are not relevant/clinically important to me6.1% Quality is not high4.0% Learning objectives are not clear1.1% Not offered at convenient times16.6% Formats are not flexible enough3.2% Not enough skill building exercise6.7% I do not have any barriers19.3% North AfricaNumber of respondents included in analysis (N)45What is missing from the CME/CPD currently available to you? Ability to choose education that suits my specific needs42.4% Ability to keep up to date with the most current research26.7% Ability to network with colleagues40.0% Content that is current/up to date20.0% Variety of educational formats (ie. Live, online, web-based, experiential, preceptorships)28.9% Innovative learning environments and new creative formats33.3% More frequent and more diverse programs35.6% Patient-focused programs24.4% Not applicable enough2.2% Nothing is missing6.7%What are your barriers to participating in CME/CPD (if any)? Not covered in my budget26.7% Topics are not relevant/clinically important to me6.7% Quality is not high2.2% Learning objectives are not clear6.7% Not offered at convenient times13.3% Formats are not flexible enough2.2% Not enough skill building exercise11.1% I do not have any barriers8.9% Not covered in my budget (26.7%) Not covered in my budget (26.7%) Not offered at convenient times (13.3%) Not offered at convenient times (13.3%) Not enough skill building exercise (11.1%) Not enough skill building exercise (11.1%) Table 6.Perceptions of In-country physicians: missing from CME/CPD System and barriers to participation. Middle EastNumber of respondents included in analysis (N)374What is missing from the CME/CPD currently available to you? Ability to choose education that suits my specific needs28.3% Ability to keep up to date with the most current research20.3% Ability to network with colleagues20.6% Content that is current/up to date13.9% Variety of educational formats (ie. Live, online, web-based, experiential, preceptorships)20.9% Innovative learning environments and new creative formats19.8% More frequent and more diverse programs19.5% Patient-focused programs23.3% Not applicable enough9.1% Nothing is missing11.0%What are your barriers to participating in CME/CPD (if any)? Not covered in my budget16.6% Topics are not relevant/clinically important to me6.1% Quality is not high4.0% Learning objectives are not clear1.1% Not offered at convenient times16.6% Formats are not flexible enough3.2% Not enough skill building exercise6.7% I do not have any barriers19.3% North AfricaNumber of respondents included in analysis (N)45What is missing from the CME/CPD currently available to you? Ability to choose education that suits my specific needs42.4% Ability to keep up to date with the most current research26.7% Ability to network with colleagues40.0% Content that is current/up to date20.0% Variety of educational formats (ie. Live, online, web-based, experiential, preceptorships)28.9% Innovative learning environments and new creative formats33.3% More frequent and more diverse programs35.6% Patient-focused programs24.4% Not applicable enough2.2% Nothing is missing6.7%What are your barriers to participating in CME/CPD (if any)? Not covered in my budget26.7% Topics are not relevant/clinically important to me6.7% Quality is not high2.2% Learning objectives are not clear6.7% Not offered at convenient times13.3% Formats are not flexible enough2.2% Not enough skill building exercise11.1% I do not have any barriers8.9% Perceptions of In-country physicians: missing from CME/CPD System and barriers to participation. Preparation as Life-Long Learner and Consultant More respondents from the Middle East cohort (40.9%) reported that their undergraduate training prepared them to be a lifelong learner as compared to respondents from the North Africa cohort (24.5%) and reported that their postgraduate training prepared them to practice as a consultant (Middle East: 53.7%; and North Africa: 42.2%). Qualitative Survey Data Overall, qualitative data collected via the electronic survey substantiated the quantitative survey findings. In the Middle East cohort, some respondents reported that the CME/CPD systems in their countries were good, and they had no additional suggestions. When offering suggestions, respondents reported that they recommended reducing costs, increasing the CME/CPD opportunities to better align with their areas of clinical speciality, and to implement mandatory requirements. Respondents from the North Africa cohort reported a need to better fund CME/CPD for physicians. Qualitative Data from the In-Country SME 1:1 Interviews Discussion from the in-country SME interviews expanded the overall findings of this assessment. Middle East Cohort (Kingdom of Bahrain, Dubai (UAE), Egypt, Israel, Jordan, KSA, Kuwait, Lebanon, Oman, and Qatar) In-country SMEs in the Middle East cohort focused primarily on improving the existing structure, improving quality, and measuring impact within their CME/CPD systems as their systems were already well established. In-country SMEs in several countries recommended expanding their accreditation systems, increasing more active learning engagement strategies, implementing evaluation strategies to assess impact of participation in CME/CPD, and better aligning CME/CPD with country-level practice gaps and health care needs. In-country SMEs also recommended developing more independent funding sources for physicians to participate in CME/CPD, implementing protected time for education, and continuing to expand interprofessional continuing education. North Africa Cohort (Algeria and Morocco) As compared to the Middle East cohort, the in-country SMEs recognised that their CME/CPD systems are in very early stages of maturity. As there is no regulation or oversight of CME/CPD in Algeria and Morocco, in-country SMEs recommended implementing a structured system that is based on standards, is regulated, and is widely available at little to no cost for physicians. The CME/CPD in Algeria and Morocco is currently driven primarily by the pharmaceutical industry and content is focused on clinical areas of therapeutic interest, therefore there is little to no content that is tied to practice gaps or country-level health needs. In-country SMEs recommended developing funding sources outside of the pharmaceutical industry, tying CME/CPD requirements to licensure, increasing faculty development support, expanding reach, and implementing methods to evaluate effectiveness. Interprofessional continuing education was not seen as a priority by the in-country SMEs at this time. Discussion Results from this assessment of CME/CPD systems across the Middle East and North Africa and from In-country SME interviews depict systems that are more robust and structured in some countries while in other countries, they are in the very early stages of maturity. Opportunities to expand scope, depth and impact therefore vary accordingly. Regional Overview Across the countries reviewed in this assessment, academic preparation for physicians is relatively consistent. Countries offer single- or dual-model paths that incorporate internship or residency (practice-based) training and are heavily subsidised by the government or are free. A national body governs the licencing of physicians to practice medicine. The number of physicians per 1000 people varies widely with Bahrain, Egypt and Morocco having significantly fewer physicians as compared to the other countries in this assessment. The countries with fewer physicians per 1000 people may need to depend on a more diverse workforce to meet health care needs of the population and may need to explore or invest in more opportunities for interprofessional continuing education. The CME/CPD systems in the Middle East countries are more robust and structured as compared to the countries in North Africa. The majority of countries in the Middle East require physicians to participate in CME/CPD as a condition of licensure and although Israel, Lebanon and Oman do not require participation, physicians are strongly encouraged to engage in continuing education. In the North Africa countries included in this assessment, there are no structured CME/CPD systems and there are no requirements for physicians to engage in continuing education to practice medicine. Of the countries evaluated in this assessment, only the countries in the Middle East cohort have established formal CME/CPD systems which include governing bodies, standards, credit systems, and tracking mechanisms. In the countries with formal CME/CPD systems, there is a CME/CPD credit system that is used to validate and/or track physician participation regardless of whether the credit is required to practice medicine. There are also incentive and/or employer-mandated requirements for physicians to engage in continuing education thus ensuring that there is a commitment to lifelong learning. The credit systems in countries with formal CME/CPD systems reflect hours of participation in an educational activity or credit that is awarded in self-directed learning. The currency of CME/CPD may be awarded in hours, units or credits. The currency can then be used to determine if a physician has met expected requirements, and if not, a governing body determines what actions would be taken against a physician’s licence and/or ability to practice medicine. In the countries without formal CME/CPD systems, there is no regulation, no standards, no formal credit system, and no mechanisms to track participation as there are no repercussions for not engaging in continuing education, although physicians may be awarded a certificate of attendance. Regardless of whether there is a formal CME/CPD system, physicians in all countries can access a variety of different formats for educational activities or self-directed learning. The CME/CPD systems, when regulated, are done so by the same governing body for the practice of medicine or are led by a medical professional association. In countries with mandatory CME/CPD as a condition of licensure, pharmaceutical companies may not control the content of educational activities; however, pharmaceutical companies are permitted to provide funding support that can be used by the educational provider to independently develop and provide CME/CPD. In countries without mandatory CME/CPD as a condition of licensure, there is more influence by pharmaceutical companies over content. In countries without structured CME/CPD systems, pharmaceutical companies provide the majority of continuing education directly to physicians. In-country SMEs noted that implementation of accreditation systems such as the ACCME in the US have led to the separation of pharmaceutical influence over control of content. The availability and interest in interprofessional continuing education (IPCE) is one of the aspects of the CME/CPD systems in these countries that demonstrates the greatest variation. In some countries, IPCE is the predominant method of designing and delivering continuing education while in other countries, there is an absence of any investment in team-based education. Best Practices in CME/CPD Systems The CME/CPD systems that support physicians and other HCPs to engage in life-long learning vary widely across different countries yet are critical to improving health care practice, and patient and population health outcomes. Best practices for CME/CPD systems should demonstrate that they are based on adult learning principles, are aligned with contemporary learning science frameworks, include mechanisms to ensure quality and independence, provide educational opportunities in multiple formats and via multiple modes of delivery, and are easily accessible and affordable. Regulatory mechanisms should be driven by the profession, include methods to validate learner participation, and should be clearly understood by all stakeholders. Systems should incorporate strategies for self-assessment, be based on identified practice gaps for individuals and health care teams, and include evaluation of change (learner, practice, and health outcomes). There should be an investment in developing HCPs as lifelong learners, interprofessional team members, and teachers. Comparison of CME/CPD Systems in the Middle East and North Africa to Best Practices This assessment of the CME/CPD systems in the Middle East and North Africa reflects wide variation and comparison of the systems to best practices is best accomplished by separating the two cohorts. Middle East Overall, the CME/CPD systems in the Middle East are mature. They are structured and regulated through governmental agencies, or medical associations. Participation in CME/CPD is required as a condition of licensure in the majority of countries, or there are strong incentives for physicians to engage. There are formal credit systems even when participation is not mandatory, and physicians have access to multiple different types of educational opportunities. There are a variety of types of organisations that can provide CME/CPD, and physicians can engage in both educational provider-directed CME/CPD as well as self-directed education for credit. There is a commitment in most countries to limit the influence of pharmaceutical companies over control of CME/CPD through implementing accreditation systems such as ACCME standards, or the profession has implemented ethical standards for physicians that address independence. Since most countries have mature systems, there is a focus on increasing the quality of education and better aligning education with practice gaps. There is a focus on improving faculty skills, moving to more active learning engagement strategies, and expanding patient-focused, clinically relevant content. IPCE, while seen as a priority across countries, is still evolving. Although IPCE is rare in some countries, which may reflect more hierarchical systems, in other countries it is the predominate style of continuing education. North Africa There are no structured CME/CPD systems in Algeria and Morocco. There are no requirements for physicians to engage in continuing education and there is no established credit or tracking system; however, physicians may be awarded certificates of attendance. The pharmaceutical industry funds and provides most CME/CPD for physicians and content is primarily in their therapeutic areas of interest. There is a lack of alignment between education that is provided and practice or country-level needs with the exception of alignment in certain areas that are driven by socio demographic and epidemiological data, such as a focus on diabetes and heart disease. Limitations There are significant limitations to this assessment. As the survey was disseminated using a snowball strategy, it was not possible to calculate an accurate response rate. Using the number of physicians in the Middle East and North Africa, the response rate was very low, and the results may not accurately reflect the perspectives of the broader physician community. The results predominantly reflect the countries of Israel and Egypt in the Middle East and Algeria and Morocco in North Africa. The SMEs participating in the assessment may have a limited or biased perspective of the CME/CPD system and therefore may not reflect the broader physician community, although efforts were made to include SMEs who were actively engaged in and able to critically assess their country systems. A more rigorous sampling strategy would have increased validity of the results. Finally, the assessment was conducted during the global COVID-19 pandemic which could have impacted survey participation. Conclusions This mixed-method assessment conducted across the Middle East and North Africa describes the current state of the CME/CPD systems in the regions. The results of this assessment were strongly influenced by Egypt and Israel in the Middle East, and Algeria and Morocco in North Africa. The CME/CPD systems demonstrate wide variation from absent/immature systems to robust/mature systems. Strategies to improve the quality of the CME/CPD systems range from implementing basic standards in North Africa to evaluating the impact of CME/CPD in practice in the Middle East. Maturity of CME/CPD systems seems to impact physician awareness, independence from the influence of pharmaceutical companies over education, and IPCE with more mature systems having a positive relationship with awareness, independence and engagement in IPCE. Maturity of CME/CPD systems is less tied to physician perceptions of value of CME/CPD, hours of participation, perceptions of what is missing from current systems, and preferred formats of education. Supplementary Material Appendix B_Survey_English.docx Appendix A_MENA Summary Characteristics Part 2.docx Appendix C_Interview Questions.docx Appendix A_MENA Summary Characteristics Part 1.docx